HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shouzhi Yu Selected Research

COVID-19

1/2024Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity.
1/2020Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shouzhi Yu Research Topics

Disease

2COVID-19
01/2024 - 01/2020
2Infections
01/2024 - 01/2020
1Poliomyelitis (Polio)
12/2022
1Tetanus
12/2022
1Diphtheria
12/2022
1Whooping Cough (Pertussis)
12/2022

Drug/Important Bio-Agent (IBA)

3VaccinesIBA
01/2024 - 01/2020
1Inactivated VaccinesIBA
01/2024
1COVID-19 VaccinesIBA
01/2024
1AluminumIBA
01/2024
1BIBP COVID-19 vaccineIBA
01/2020